Skip to main content
SWOG logo

User account menu

  • Log in

Main navigation

  • About
    • History & Impact
    • Mission & Values
    • Leadership
    • Support SWOG
    • Join SWOG
    • Policies & Procedures
    • Careers
    • Contact Us
  • The SWOG Network
    • How We Work
    • Our Staff
    • Our Advocates
    • Our Partners
  • News & Events
    • News
    • SWOG Meetings
    • For Press
  • Clinical Trials
    • Biospecimen Submission
    • Biospecimen Access
    • Data Requests
    • Clinical Trials Search
    • Clinical Research Resources
    • Frequently Asked Questions
    • Publications
    • Institutions
    • Quality Assurance & Audits
    • Serious Adverse Events
    • Training Resources
    • ORP (CRA) Workbench
    • Protocol Workbench
  • Workbenches
    • ORP (CRA) Workbench
    • Protocol Workbench
    • VA Workbench
  • For Patients
    • Patient & Advocate Voices
    • Trials Open to Patients
    • About SWOG Cancer Trials
    • Joining a Trial

Breadcrumb

  1. SWOG
  2. News & Events
  3. News
  4. News

News

SIGN UP FOR EMAIL UPDATES
New new Front Line image
The Front Line
Jan 17, 2020

Rad Oncs Poised to Progress in Precision Era

Wendy Woodward
Press Release
Jan 9, 2020

Gene Recurrence Score May Help in RadOnc RX

Lung-MAP logo
Jan 6, 2020

Lung-MAP Newsletter Winter 2020

New new Front Line image
The Front Line
Dec 27, 2019

Gratitude for Another Great Year

New new Front Line image
The Front Line
Dec 20, 2019

Women Continue To Rise in SWOG Research

Dr. Christine Ambrosone
Press Release
Dec 19, 2019

Antioxidant Use During Chemo Risky

San Antonio Breast Cancer Symposium
Press Release
Dec 13, 2019

PROs Predict Aromatase Inhibitor Adherence

Dr. Annette Hay
Press Release
Dec 9, 2019

Leukemia Combo Toxic for Old, Frail Patients

Dr. Daniel Persky
Press Release
Dec 8, 2019

No Radiation OK for Some Lymphoma Patients

  • Previous page ‹
  • First page 1
  • …
  • Page38
  • Current page39
  • Page40
  • …
  • Last page 65
  • Next page ›
SWOG logo

Footer: Social Links

  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025

Footer

  • Disclaimer